Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.artemishospitals.com | |
Market Cap | 2,150.67 Cr. | |
Enterprise Value(EV) | 2,341.27 Cr. | 2023-03 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 2.94 | Trailing Twelve Months Ending 2023-06 |
Price-Earning Ratio (PE) | 53.80 | Trailing Twelve Months Ending 2023-06 |
Industry PE | 55.63 | Trailing Twelve Months Ending 2023-06 |
Book Value / Share | 24.85 | Trailing Twelve Months Ending 2023-06 |
Price to Book Value | 6.37 | Calculated using Price: 158.40 |
Dividend Yield | 0.28 | Period Ending 2023-03 |
No. of Shares Subscribed | 13.59 Cr. | 135,860,500 Shares |
FaceValue | 1 | |
About Artemis Medicare Services Ltd. | ||
The Company is engaged in the business of managing and operating of multi specialty hospitals. |
1 Day |
|
+0.76% |
1 Week |
|
+10.04% |
1 Month |
|
+29.04% |
3 Month |
|
+33.60% |
6 Month |
|
+143.92% |
1 Year |
|
+160.31% |
2 Year |
|
+348.09% |
5 Year |
|
|
10 Year |
|
5 years | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 9.50 | 8.43 | 2.46 | 11.66 | 12.41 | |
Return on Capital Employed (%) | 13.96 | 12.64 | 5.63 | 11.47 | 13.34 | |
Return on Assets (%) | 3.68 | 3.41 | 1.03 | 4.71 | 4.59 |
Particulars | 5 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Shh. Funds | 293 | 313 | 320 | 359 | 403 | |
Non Curr. Liab. | 84 | 115 | 168 | 226 | 317 | |
Curr. Liab. | 177 | 158 | 118 | 138 | 206 | |
Minority Int. | 0 | 0 | 2 | 2 | 5 | |
Equity & Liab. | 554 | 586 | 609 | 726 | 930 | |
Non Curr. Assets | 442 | 469 | 499 | 599 | 760 | |
Curr. Assets | 113 | 118 | 109 | 127 | 170 | |
Misc. Exp. not W/O | ||||||
Total Assets | 554 | 586 | 609 | 726 | 930 |
Particulars | 6 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-06 Rs. Cr. TTM |
Net Sales | 547 | 565 | 408 | 555 | 737 | 780 | |
Other Income | 4 | 5 | 4 | 5 | 7 | 6 | |
Total Income | 551 | 570 | 412 | 560 | 745 | 786 | |
Total Expenditure | -483 | -504 | -373 | -488 | -643 | -677 | |
PBIDT | 68 | 66 | 39 | 71 | 101 | 109 | |
Interest | -11 | -13 | -13 | -12 | -20 | -22 | |
Depreciation | -20 | -23 | -22 | -22 | -31 | -34 | |
Taxation | -16 | -11 | -1 | -6 | -13 | -14 | |
Exceptional Items | 3 | ||||||
PAT | 20 | 19 | 6 | 31 | 38 | 40 | |
Minority Interest | 0 | 0 | 0 | 0 | 1 | 1 | |
Share Associate | |||||||
Other Related Items | |||||||
Consolidated Net Profit | 20 | 20 | 6 | 32 | 39 | 40 | |
Adjusted EPS | 2 | 0 | 2 | 3 | 3 |
Particulars | 5 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 40 | 56 | 27 | 60 | 127 | |
Cash Fr. Inv. | -50 | -26 | -37 | -107 | -158 | |
Cash Fr. Finan. | 14 | -27 | 18 | 44 | 38 | |
Net Change | 5 | 2 | 8 | -3 | 7 | |
Cash & Cash Eqvt | 9 | 12 | 19 | 16 | 23 |
Fri, 29 Sep 2023
Closure of Trading Window Closure of Trading Window. |
Sat, 09 Sep 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find below the proposed schedule of Investors/ Analysts Meeting with the Company on September 15 2023. |
Sat, 09 Sep 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find below the proposed schedule of Investors/ Analysts Meeting with the Company on September 14 2023. |
Fri, 29 Sep 2023 |
|
|
|
|
|